227 related articles for article (PubMed ID: 31197071)
21. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
[TBL] [Abstract][Full Text] [Related]
23. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
[TBL] [Abstract][Full Text] [Related]
24. Richter Transformation Arising From Chronic Lymphocytic Leukemia.
Barnes Rogers B
Clin J Oncol Nurs; 2022 Feb; 26(1):14-17. PubMed ID: 35073287
[TBL] [Abstract][Full Text] [Related]
25. Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.
Miller CR; Ruppert AS; Heerema NA; Maddocks KJ; Labanowska J; Breidenbach H; Lozanski G; Zhao W; Gordon AL; Jones JA; Flynn JM; Jaglowski SM; Andritsos LA; Blum KA; T Awan F; Rogers KA; Grever MR; Johnson AJ; Abruzzo LV; Hertlein EK; Blachly JS; Woyach JA; Byrd JC
Blood Adv; 2017 Aug; 1(19):1584-1588. PubMed ID: 29296799
[TBL] [Abstract][Full Text] [Related]
26. Richter syndrome: biology, incidence, and therapeutic strategies.
Tsimberidou AM; Keating MJ
Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
28. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
Jamroziak K; Tadmor T; Robak T; Polliack A
Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience.
Kharfan-Dabaja MA; Kumar A; Stingo FE; Khimani F; Hussaini M; Ayala E; Nishihori T; Shah B; Locke FL; Pinilla-Ibarz J; Chavez JC
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e35-e39. PubMed ID: 29126867
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
Chen AI; Leonard JT; Okada CY; Gay ND; Chansky K; Fan G; Dunlap JB; Raess PW; Braziel RM; Stentz A; Maziarz RT
Leuk Lymphoma; 2018 Aug; 59(8):1884-1889. PubMed ID: 29199519
[TBL] [Abstract][Full Text] [Related]
33. Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.
Morscio J; Bittoun E; Volders N; Lurquin E; Wlodarska I; Gheysens O; Vandenberghe P; Verhoef G; Demaerel P; Dierickx D; Sagaert X; Janssens A; Tousseyn T
J Hematop; 2016; 9():113-120. PubMed ID: 29861791
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic Cell Transplantation for Richter Syndrome.
El-Asmar J; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1938-1944. PubMed ID: 27375122
[TBL] [Abstract][Full Text] [Related]
35. Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas.
Willenbacher E; Willenbacher W; Weger R; Dominik W; Manzl C; Brunner A
Ann Hematol; 2020 Sep; 99(9):2125-2132. PubMed ID: 32613279
[TBL] [Abstract][Full Text] [Related]
36. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Ding W; LaPlant BR; Call TG; Parikh SA; Leis JF; He R; Shanafelt TD; Sinha S; Le-Rademacher J; Feldman AL; Habermann TM; Witzig TE; Wiseman GA; Lin Y; Asmus E; Nowakowski GS; Conte MJ; Bowen DA; Aitken CN; Van Dyke DL; Greipp PT; Liu X; Wu X; Zhang H; Secreto CR; Tian S; Braggio E; Wellik LE; Micallef I; Viswanatha DS; Yan H; Chanan-Khan AA; Kay NE; Dong H; Ansell SM
Blood; 2017 Jun; 129(26):3419-3427. PubMed ID: 28424162
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Richter's Syndrome.
Condoluci A; Rossi D
Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
[TBL] [Abstract][Full Text] [Related]
38. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
39. COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.
Barraclough A; Alzahrani M; Ettrup MS; Bishton M; van Vliet C; Farinha P; Gould C; Birch S; Sehn LH; Sovani V; Ward MS; Augustson B; Biccler J; Connors JM; Scott DW; Gandhi MK; Savage KJ; El-Galaly T; Villa D; Cheah CY
Blood Adv; 2019 Jul; 3(13):2013-2021. PubMed ID: 31285189
[TBL] [Abstract][Full Text] [Related]
40. Ophthalmic involvement of chronic lymphocytic leukemia: A systematic review of 123 cases.
Delestre F; Blanche P; Bouayed E; Bouscary D; Mouthon L; Brezin A; Le Jeunne C; Chaigne B
Surv Ophthalmol; 2021; 66(1):124-131. PubMed ID: 32407752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]